Compound class:
Synthetic organic
Comment: Benapenem is a carbapenem (β-lactam) with broad-spectrum antibacterial activity [2]. It has advanced to clinical evaluation as an intravenous treatment for urinary tract infections.
|
|
No information available. |
Summary of Clinical Use ![]() |
Benapenem, like ertapenem, has a longer serum half-life (~7 h) than other prescribed carbapenems making it suitable for once-daily administration [2]. Benapenem has progressed to Phase 2/3 evaluation as a treatment for complicated urinary tract infection (cUTI) and acute pyelonephritis (NCT04505683, recruitment completed). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04505683 | A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) | Phase 2/Phase 3 Interventional | Sihuan Pharmaceutical Holdings Group Ltd. |